Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes

Frank D. Lee

Chief Executive Officer and Director

Mr. Lee joined Pacira as Chief Executive Officer and member of the Board of Directors in January 2024. An accomplished biopharmaceutical leader, Mr. Lee brings thirty years of global experience and a strong track record of product development and commercial success across both small biotech and large pharmaceutical organizations. He most recently served as Chief Executive Officer and member of the Board of Directors of publicly traded Forma Therapeutics from March 2019 until its acquisition by Novo Nordisk in October 2022. During his tenure at Forma, Mr. Lee transformed the organization from an early-stage drug discovery company into one focused on the clinical development of lead assets in rare hematologic disorders and cancer. Prior to Forma, Mr. Lee served as Senior Vice President, Global Product Strategy and Therapeutic Area Head for Immunology, Ophthalmology and Infectious Diseases at Genentech, a member of the Roche Group. He was responsible for driving the global development and commercialization strategy for the late-stage portfolio, and for global portfolio product sales of $11 billion. Mr. Lee’s 13-year tenure at Genentech included leadership positions of increasing scope and responsibility focused on delivering transformative medicines to patients and driving the growth of multiple in oncology, immunology and ophthalmology products to blockbuster/multi-blockbuster status. Prior to Genentech, Mr. Lee spent approximately 13 years across Novartis, Janssen and Eli Lilly. He received a Bachelor of Science degree in Chemical Engineering from Vanderbilt University and an MBA from the Wharton Graduate School of Business. Mr. Lee currently serves as a Director of Bausch Health Companies, Inc. (NYSE: BHC) and as an Advisor to Lightstone Ventures.

Daryl Gaugler

Chief Operating Officer

Daryl Gaugler is Chief Operating Officer at Pacira, responsible for overseeing Sales, Commercial Operations, Reimbursement, Sports Accounts, Health System Alliance, Learning and Development, and Marketing and Communications. He previously served as Senior Vice President of Commercial Operations, a role he held at the company since June 2019. Prior to joining Pacira, Mr. Gaugler spent over 20 years with the Quintiles Transnational organization (now IQVIA), most recently as President of North American Commercial Solutions. Mr. Gaugler delivered significant revenue and profit growth while leading customer satisfaction and employee engagement within the organization. He is a seasoned life sciences executive with 30 years of experience in commercial leadership that includes building and directing over 400 commercial teams and designing go-to-market strategies for more than 20 companies. Mr. Gaugler holds a Bachelor of Science in Business Administration from Shippensburg University.

Kristen Williams, JD

Chief Administrative Officer and Secretary

Kristen Williams worked with the company as a legal consultant before joining as Corporate Counsel in December 2011. Since then, she has been promoted to Vice President, General Counsel in 2013 and to Chief Administrative Officer, General Counsel and Secretary in 2014. Prior to joining Pacira, she was Vice President, Corporate Compliance and Assistant General Counsel for Bioenvision, Inc from June 2004 until its merger with Genzyme Corporation in 2007. From September 1999 to June 2004, she practiced corporate law at Paul Hastings LLP in New York, where her practice encompassed all aspects of public and private mergers and acquisitions, corporate finance, and securities law and compliance, with a core focus in the healthcare industry.

Ms. Williams earned a Bachelor of Science Degree in Business Administration from Bucknell University and a J.D. Degree from the University of Denver, College of Law in Denver, CO.

Jonathan Slonin, MD

Chief Medical Officer

Dr. Jonathan Slonin joined Pacira in 2020 and most recently served as Chief Clinical Officer, directing the Company’s customer-facing medical operations and iovera device franchise. As Chief Medical Officer, Dr. Slonin will oversee research and development and all customer-facing medical operations in addition to clinical, R&D, and medical strategy. He brings over 15 years of experience to Pacira as a board-certified anesthesiologist who has held numerous clinical and leadership positions with TeamHealth and Envision Healthcare including Regional Medical Director for the Southeast with TeamHealth and Chairman of Anesthesiology for the Cleveland Clinic Martin Health. Dr. Slonin received his Bachelor of Science in Biomedical Engineering and his MD degree from the University of Miami. He completed his anesthesiology residency at University of Miami/Jackson Memorial Hospital where he served as chief resident. Dr. Slonin received his MBA degree from George Washington University.

Lauren Riker

Interim Chief Financial Officer

Lauren Riker joined Pacira in 2011 and currently serves as our interim Chief Financial Officer. She held the position of Senior Vice President of Finance from 2021 to 2024, Vice President of Finance from 2015 to 2021, and Executive Director, Accounting and Financial Reporting from 2011 to 2015. Prior to joining Pacira, Ms. Riker was Senior Director of Financial Reporting at Ikaria, Inc., a private critical care biopharmaceutical company, from 2008 to 2011. Before her tenure at Ikaria, Ms. Riker was Controller and then Chief Accounting Officer at Bioenvision, Inc., a publicly traded biotechnology company, from 2004 until its merger with Genzyme Corporation in 2007. Ms. Riker is a Certified Public Accountant who earned her Bachelor of Science in Accounting from Boston College and her MBA from Columbia Business School.

Christopher Young

Chief Manufacturing Officer

Christopher Young joined Pacira in 2023 and currently serves as Chief Manufacturing Officer. In this role he oversees all manufacturing activities across the Pacira product portfolio including supply chain design, product life cycle management, demand and requirements planning, capacity, and product launches across all global manufacturing locations. Prior to joining Pacira, Chris served as Executive Vice President, Global Operations at Akorn Inc, where he oversaw manufacturing at four global sites and directed global operations, procurement, supply chain, technical services, engineering, security, and distribution. Previous to his tenure at Akorn, Chris spent five years as Executive Vice President, Global Operations at Alvogen Inc with similar responsibilities including managing employees, operations and capital budgets at five manufacturing sites, directing technical transfer, and operational excellence in support of $1 billion in sales worldwide. Chris has also held positions of increasing responsibility at Actavis/Alpharma/Purepac Pharmaceutical Co, Zenith Goldline Pharmaceuticals, and Copley Pharmaceutical, Inc. He holds a Bachelor of Science degree from Gettysburg College and a Master of Business Administration degree from Rutgers University.

Anthony Molloy III, Esq.

Chief Legal and Compliance Officer

Anthony Molloy started as Associate General Counsel in December 2013. Since then, he has been promoted to Vice President, General Counsel in 2016 and to Senior Vice President, General Counsel and Deputy Compliance Officer in 2021. A licensed patent attorney, prior to joining Pacira, he practiced IP law and litigated at Patton Boggs LLP in Newark, NJ from April 2006 to November 2013. From 1998 to 2004, prior to law school, Mr. Molloy worked as a Chemical Engineer specializing in polymer chemistry in the R&D group of The Okonite Company.

Mr. Molloy earned a Bachelor of Arts Degree in Chemistry from SUNY Geneseo, a Bachelor of Science Degree in Chemical Engineering from SUNY Buffalo, a Masters Degree in Technology Management from Stevens Institute of Technology, and his J.D. Degree from Rutgers Law School - Newark.